Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved Localization of Insulinomas Using 68Ga-NODAGA-Exendin-4 PET/CT.
Boss M, Eriksson O, Mikkola K, Eek A, Brom M, Buitinga M, Brouwers AH, Velikyan I, Waser B, Kauhanen S, Solin O, Marciniak C, Eriksson B, Reubi JC, Aveline C, Wild D, Pattou F, Talbot JN, Hofland J, Sundin A, Nuutila P, Hermans J, Gotthardt M. Boss M, et al. Among authors: talbot jn. J Nucl Med. 2024 Dec 3;65(12):1959-1964. doi: 10.2967/jnumed.124.268158. J Nucl Med. 2024. PMID: 39419553 Free PMC article.
18F-Fluorocholine-Positron Emission Tomography/Computerized Tomography (FCH PET/CT) Imaging for Detecting Abnormal Parathyroid Glands: Indication, Practice, Interpretation and Diagnostic Performance.
Noskovicova L, Balogova S, Aveline C, Tassart M, Zhang-Yin J, Kerrou K, Jaksic I, Montravers F, Talbot JN. Noskovicova L, et al. Among authors: talbot jn. Semin Nucl Med. 2024 Nov;54(6):875-895. doi: 10.1053/j.semnuclmed.2024.08.002. Epub 2024 Sep 20. Semin Nucl Med. 2024. PMID: 39306520
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.
Pasquier D, Bidaut L, Oprea-Lager DE, deSouza NM, Krug D, Collette L, Kunz W, Belkacemi Y, Bau MG, Caramella C, De Geus-Oei LF, De Caluwé A, Deroose C, Gheysens O, Herrmann K, Kindts I, Kontos M, Kümmel S, Linderholm B, Lopci E, Meattini I, Smeets A, Kaidar-Person O, Poortmans P, Tsoutsou P, Hajjaji N, Russell N, Senkus E, Talbot JN, Umutlu L, Vandecaveye V, Verhoeff JJC, van Oordt WMH, Zacho HD, Cardoso F, Fournier L, Van Duijnhoven F, Lecouvet FE. Pasquier D, et al. Among authors: talbot jn. Lancet Oncol. 2023 Aug;24(8):e331-e343. doi: 10.1016/S1470-2045(23)00286-3. Lancet Oncol. 2023. PMID: 37541279 Review.
18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center.
Talbot JN, Périé S, Tassart M, Delbot T, Aveline C, Zhang-Yin J, Kerrou K, Gaujoux S, Wagner I, Bennis M, Ménégaux F, Breton S, Cochand-Priollet B, Christin-Maitre S, Groussin L, Haymann JP, Baujat B, Balogova S, Montravers F. Talbot JN, et al. Q J Nucl Med Mol Imaging. 2023 Jun;67(2):96-113. doi: 10.23736/S1824-4785.23.03513-6. Epub 2023 Mar 30. Q J Nucl Med Mol Imaging. 2023. PMID: 36995286 Free article.
An essential practice summary of the new EANM guidelines for parathyroid imaging.
Petranović Ovčariček P, Giovanella L, Hindie E, Huellner MW, Talbot JN, Verburg FA. Petranović Ovčariček P, et al. Among authors: talbot jn. Q J Nucl Med Mol Imaging. 2022 Jun;66(2):93-103. doi: 10.23736/S1824-4785.22.03427-6. Epub 2022 Feb 15. Q J Nucl Med Mol Imaging. 2022. PMID: 35166093 Free article.
Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET/CT. Illustrative cases and pitfalls.
Talbot JN, Zhang-Yin J, Kerrou K, Aveline C, Vagne B, Bélissant O, Tassart M, Périé S, Bouchard P, Christin-Maitre S, Ménégaux F, Groussin L, Gaujoux S, Balogová S, Montravers F. Talbot JN, et al. Q J Nucl Med Mol Imaging. 2022 Jun;66(2):130-140. doi: 10.23736/S1824-4785.22.03440-9. Epub 2022 Jan 10. Q J Nucl Med Mol Imaging. 2022. PMID: 35005879 Free article.
220 results